Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use

Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use

US Patent 12215157 · Granted Feb 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glypican-3-binding fibronectin based scaffold molecules2025
Human PD-L2 antibodies and methods of use therefor2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025